DelMar Pharmaceuticals, Inc.

DelMar Pharmaceuticals, Inc.verified

DMPWW

Price:

$0.0001

Market Cap:

$52.17M

Kintara Therapeutics, Inc., a clinical stage drug development company, focuses on developing and commercializing anti-cancer therapies to treat cancer patients. It is developing two late-stage, Phase III-ready therapeutics, including VAL-083, a DNA-targeting agent for the treatment of drug-resistant solid tumors, such as glioblastoma multiforme, as well as other solid tumors, including ovarian cancer, non-small cell lung cancer, and diffuse intrinsic pontine glioma; and REM-001, a late stage photodynamic therapy for the treatment of cutaneous metastatic breast cancer, basal cell carcinoma nevus syndrome, and access graft failure in hemodialysis patients. Kintara Therapeutics, Inc. has a stra...[Read more]

Industry

Biotechnology

IPO Date

Stock Exchange

OTC

Ticker

DMPWW

The Enterprise Value as of December 2025 (TTM) for DelMar Pharmaceuticals, Inc. (DMPWW) is 44.21M

According to DelMar Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 44.21M. This represents a change of -32.99% compared to the average of 65.98M of the last 4 quarters.

DelMar Pharmaceuticals, Inc. (DMPWW) Historical Enterprise Value (quarterly & annually)

How has DMPWW Enterprise Value performed in the past?

The mean historical Enterprise Value of DelMar Pharmaceuticals, Inc. over the last ten years is 1.90M. The current 44.21M Enterprise Value has changed 232.26% with respect to the historical average. Over the past ten years (40 quarters), DMPWW's Enterprise Value was at its highest in in the December 2024 quarter at 160.65M. The Enterprise Value was at its lowest in in the September 2020 quarter at -21476820.00.

Quarterly (TTM)
Annual

Average

1.90M

Median

-3947047.84

Minimum

-13795390.35

Maximum

63.88M

DelMar Pharmaceuticals, Inc. (DMPWW) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of DelMar Pharmaceuticals, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 2.12%

Maximum Annual Enterprise Value = 63.88M

Minimum Annual Increase = -120.83%

Minimum Annual Enterprise Value = -13795390.35

Quarterly (TTM)
Annual
YearEnterprise ValueChange
202463.88M2.12%
20232.87M-120.83%
2022-13795390.35229.06%
2021-4192344.50-52.67%
2021-8858221.50305.10%
2020-2186700.80-39.67%
2019-3624614.00-34.87%
2018-5564938.92-4.02%
2017-5797811.4956.62%
2016-3701751.18252.30%

DelMar Pharmaceuticals, Inc. (DMPWW) Average Enterprise Value

How has DMPWW Enterprise Value performed in the past?

The current Enterprise Value of DelMar Pharmaceuticals, Inc. (DMPWW) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

17.65M

5-year avg

7.98M

10-year avg

1.90M

DelMar Pharmaceuticals, Inc. (DMPWW) Enterprise Value vs. Peers

How is DMPWW’s Enterprise Value compared to its peers?

DelMar Pharmaceuticals, Inc.’s Enterprise Value is greater than Kiromic BioPharma, Inc. (13.65M), greater than Hemogenyx Pharmaceuticals Plc (37.91M), greater than Vitalibis, Inc. (1.32M), greater than Evome Medical Technologies Inc. (19.72M), greater than ProSomnus, Inc. (42.48M), greater than Advanced Proteome Therapeutics Corporation (-63027.00), greater than CuraScientific Corp (3.01M), greater than TRACON Pharmaceuticals, Inc. (-7486275.00), greater than Molecular Templates, Inc. (707.66K), greater than Predictive Technology Group, Inc. (7.60M),

Build a custom stock screener for DelMar Pharmaceuticals, Inc. (DMPWW) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like DelMar Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

DelMar Pharmaceuticals, Inc. (DMPWW) and other stocks custom spreadsheet templates

The easiest way to analyze a company like DelMar Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is DelMar Pharmaceuticals, Inc.'s Enterprise Value?

What is the highest Enterprise Value for DelMar Pharmaceuticals, Inc. (DMPWW)?

What is the 3-year average Enterprise Value for DelMar Pharmaceuticals, Inc. (DMPWW)?

What is the 5-year average Enterprise Value for DelMar Pharmaceuticals, Inc. (DMPWW)?

How does the current Enterprise Value for DelMar Pharmaceuticals, Inc. (DMPWW) compare to its historical average?